Cargando…

Dynamic monitoring of serum tumor markers as prognostic factors in patients with advanced non-small-cell lung cancer treated with first-line immunotherapy: a multicenter retrospective study

BACKGROUND: To date, no specific studies have reported the use of dynamic serum tumor markers (STMs) as prognostic factors in patients with advanced non-small-cell lung cancer (NSCLC) who receive first-line immunotherapy. Therefore, it is unclear whether STMs can be used as a prognostic factor for f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Xiongwen, Xiao, Yi, Zhou, Yubin, Deng, Huiyin, Yuan, Zihao, Dong, Longyan, Lan, Jun, Hu, Hao, Huang, Jian, Huang, Shaohong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619361/ https://www.ncbi.nlm.nih.gov/pubmed/37920256 http://dx.doi.org/10.1177/17588359231206282

Ejemplares similares

Baseline serum tumor markers predict the survival of patients with advanced non-small cell lung cancer receiving first-line immunotherapy: a multicenter retrospective study
por: Huang, Jian, et al.
Publicado: (2023)

Survival rates of patients with tumors originating in different segments of the left upper lung in stage I to III non-small cell lung cancer
por: Xiao, Yi, et al.
Publicado: (2021)

Comparison of Immunotherapy, Chemotherapy, and Chemoimmunotherapy in Advanced Pulmonary Lymphoepithelioma-Like Carcinoma： A Retrospective Study
por: Xiao, Yi, et al.
Publicado: (2022)

Elevated tumor markers for monitoring tumor response to immunotherapy
por: Yang, Yi, et al.
Publicado: (2022)

The prognostic significance of preoperative serum albumin in urothelial carcinoma: a systematic review and meta-analysis
por: Liu, Jing, et al.
Publicado: (2018)

Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapy
por: Tuxen, M K, et al.
Publicado: (2001)

Nano‐optogenetic immunotherapy
por: Huang, Kai, et al.
Publicado: (2022)

Knockout of immunotherapy prognostic marker genes eliminates the effect of the anti-PD-1 treatment
por: Yang, Naixue, et al.
Publicado: (2021)

Genetic Diversity and Geographical Distribution of the Red Tide Species Coscinodiscus granii Revealed Using a High-Resolution Molecular Marker
por: Huang, Hailong, et al.
Publicado: (2022)

Frequency of serum tumour marker monitoring.
por: Colls, B. M.
Publicado: (1991)

The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma.
por: Gronowitz, J. S., et al.
Publicado: (1983)

SCG2: A Prognostic Marker That Pinpoints Chemotherapy and Immunotherapy in Colorectal Cancer
por: Weng, Siyuan, et al.
Publicado: (2022)

Serum Prealbumin Levels on Admission as a Prognostic Marker in Stroke Patients Treated with Mechanical Thrombectomy
por: López, Begoña, et al.
Publicado: (2022)

Serum lipid levels correlate to the progression of gastric cancer with neuroendocrine immunophenotypes: A multicenter retrospective study
por: Zou, Yi, et al.
Publicado: (2020)

Diagnostic and prognostic serum marker of cholangiocarcinoma (Review)
por: ZENG, XIAOJUN, et al.
Publicado: (2015)

NOTCH4 Is a Novel Prognostic Marker that Correlates with Colorectal Cancer Progression and Prognosis
por: Wu, Guiyang, et al.
Publicado: (2018)

Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy
por: Liikanen, Ilkka, et al.
Publicado: (2015)

BRCAness as an Important Prognostic Marker in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy: A Multicenter Retrospective Study
por: Kosaka, Yoshimasa, et al.
Publicado: (2020)

Identification of CKS1B as a prognostic indicator and a predictive marker for immunotherapy in pancreatic cancer
por: Li, Lincheng, et al.
Publicado: (2022)

Regorafenib Combined with PD-1 Blockade Immunotherapy versus Regorafenib as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Study
por: Huang, Jingjun, et al.
Publicado: (2022)

Prognostic Significance of Serum Inflammatory Markers in Gastric Cancer
por: Powell, Arfon G. M. T., et al.
Publicado: (2017)

Prognostic significance of serum inflammatory markers in esophageal cancer
por: Powell, Arfon G. M. T., et al.
Publicado: (2020)

Serum amylase as a prognostic marker of organophosphate poisoning
por: Zobeiri, Mehdi
Publicado: (2021)

Prognostic Mutational Signatures of NSCLC Patients treated with chemotherapy, immunotherapy and chemoimmunotherapy
por: Smith, Margaret R., et al.
Publicado: (2023)

The Prognostic Value of the Prognostic Nutritional Index in Patients with Advanced or Metastatic Gastric Cancer Treated with Immunotherapy
por: Pan, Yuting, et al.
Publicado: (2023)

Targeting CD47-SIRPα axis for Hodgkin and non-Hodgkin lymphoma immunotherapy
por: Zhao, Pengcheng, et al.
Publicado: (2023)

Study protocol: A single‐arm, multicenter, phase II trial of camrelizumab plus apatinib for advanced nonsquamous NSCLC previously treated with first‐line immunotherapy
por: Xing, Puyuan, et al.
Publicado: (2021)

Monitoring Autophagy in Rice With GFP-ATG8 Marker Lines
por: Liu, Rui, et al.
Publicado: (2022)

Role of antiangiogenic agents in first-line treatment for advanced NSCLC in the era of immunotherapy
por: Pang, Lan-Lan, et al.
Publicado: (2023)

FBXW7 E3 ubiquitin ligase: degrading, not degrading, or being degraded
por: Lan, Huiyin, et al.
Publicado: (2019)

Tumor Suppressor FBXW7 and Its Regulation of DNA Damage Response and Repair
por: Lan, Huiyin, et al.
Publicado: (2021)

Changes of Tumor Markers in Patients with Lung Cancer after Immunotherapy and Their Link with Inflammation in the Body
por: Liu, LiWei, et al.
Publicado: (2022)

Prognostic Value of Malondialdehyde Serum Levels in Severe Sepsis: A Multicenter Study
por: Lorente, Leonardo, et al.
Publicado: (2013)

Eosinophil and IFN-γ associated with immune-related adverse events as prognostic markers in patients with non-small cell lung cancer treated with immunotherapy
por: Hu, Wei-Ting, et al.
Publicado: (2023)

Evaluation of hippocampal volume and serum brain-derived neurotrophic factor as potential diagnostic markers of conversion from amnestic mild cognitive impairment to Alzheimer disease: A STROBE-compliant article
por: Fang, Yan, et al.
Publicado: (2019)

Monitoring regulatory T cells as a prognostic marker in lung transplantation
por: Khan, Mohammad Afzal, et al.
Publicado: (2023)

Prognostic value of serum lactate kinetics in critically ill patients with cirrhosis and acute-on-chronic liver failure: a multicenter study
por: Gao, Feng, et al.
Publicado: (2019)

DPP4 Is a Potential Prognostic Marker of Thyroid Carcinoma and a Target for Immunotherapy
por: Gao, Xiaoqian, et al.
Publicado: (2022)

Serum Metallothioneins in Childhood Tumours—A Potential Prognostic Marker
por: Kruseova, Jarmila, et al.
Publicado: (2013)

The evaluation of prognostic value of serum tumor marker in ovarian tumors
por: Sharief, S, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mras5afa9diqp92bp0m50b4t7l